Inhibitors & Activators

Inhibitors & Activators

Insulin is the principal hormone that regulates the uptake of glucose from the blood into most cells of the body, especially liver, adipose tissue and muscle, except smooth muscle, in which insulin acts via the IGF-1. The deficiency of insulin or the insensitivity of its receptors play a central role in all forms of diabetes.

Inhibitors and activators are molecules that increase or decrease the activity of enzymes or metabolites, which are critical tools for researchers in the field of cell biology to obtain a comprehensive understanding of cell function, cell signaling and the intracellular mechanisms that control cell fate, function, and phenotype.

For assisting our global customers making better progress in therapeutic development and drug discovery, Ace Therapeutics offers proteins and peptides for diabetes. As a pioneer of diabetes research, Ace Therapeutics provides the most comprehensive list of recombinant inhibitors and activators products in the world.

Inhibitors & Activators for Diabetes Research
Menin-MLL inhibitor 19 (DIA-0243328)
  • CAS Number: 2360487-93-8
  • Purity: 98.07%
  • Target: Epigenetic Reader Domain
DK1 (DIA-0243329)
  • CAS Number: 1187568-17-7
  • Purity: 99.69%
  • Target: Estrogen Receptor/ERR
BT44 (DIA-0243330)
  • CAS Number: 924759-42-2
  • Purity: 99.08%
  • Target: RET
GSK2041706A (DIA-0243331)
  • CAS Number: 1032824-43-3
  • Target: GPR119
PPARγ/GR modulator 1 (DIA-0243332)
  • Target: PPAR, Glucocorticoid Receptor
SCO-267 (DIA-0243333)
  • CAS Number: 1656261-09-4
  • Purity: 99.31%
  • Target: Free Fatty Acid Receptor
WWL123 (DIA-0243334)
  • CAS Number: 1338574-83-6
  • Purity: ≥98.0%
  • Target: MAGL
Luseogliflozin (DIA-0243335)
  • CAS Number: 898537-18-3
  • Purity: 99.20%
  • Target: SGLT
α-Glucosidase-IN-28 (DIA-0243336)
  • CAS Number: 2949513-10-2
  • Target: Glucosidase
Glucokinase activator 3 (DIA-0243337)
  • CAS Number: 1001417-92-0
  • Purity: 98.36%
  • Target: Glucokinase
logo

Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.

Quick Links
Contact Info
Copyright © Ace Therapeutics. All Rights Reserved.
Top